CORRECTION article

Front. Oncol., 07 February 2024

Sec. Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1370998

Corrigendum: LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research

    YF

    Yuan Feng

    JY

    Junjun Yang

    WD

    Wentao Duan

    YC

    Yu Cai

    XL

    Xiaohong Liu

    YP

    Yong Peng *

  • Department of Hepatobiliary Pancreatic and Spleen Surgery, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, China

Article metrics

View details

854

Views

442

Downloads

Text correction

In the published article, there was an error. “Nanchang” is the wrong spelling. The correct spelling should be “Nanchong.”

This correction has been applied to the Abstract, the Methodology under the External Validation section, and to the first line of Table 1.

Table 1

Variable Whole population Training population Validation population P Nanchong Central Hospital
Number % Number % Number % 149
17,621 12,333 5,288
Age
 50-65 6,262 35.54% 4,400 35.68% 1,862 35.21% 0.83 23
 65-80 8,585 48.72% 5,983 48.51% 2,602 49.21% 84
 80 2,774 15.74% 1,950 15.81% 824 15.58% 42
Race
 Black 2,072 11.76% 1,472 11.94% 600 11.35% 0.91 0
 White 14,135 80.22% 9,861 79.96% 4,274 80.82% 0
 Other 1,414 8.02% 1,000 8.11% 414 7.83% 149
Sex
 F 8,437 47.88% 5,919 47.99% 2,518 47.62% 0.56 64
 M 9,184 52.12% 6,414 52.01% 2,770 52.38% 85
AJCC Stages
 III 3,087 17.52% 2,172 17.61% 915 17.30% 0.47 43
 IV 14,534 82.48% 10,161 82.39% 4,373 82.70% 106
Site
 Head 8,045 45.66% 5,632 45.67% 2,413 45.63% 59
 Body 3,542 20.10% 2,500 20.27% 1,042 19.70% 0.28 18
 Tail 3,605 20.46% 2,512 20.37% 1,093 20.67% 32
 Others 2,429 13.78% 1,689 13.69% 740 13.99% 40
Grade a
 Well 1,606 9.11% 1,136 9.21% 470 8.89% 0.15 17
 Bad 1,805 10.24% 1,286 10.43% 519 9.81% 23
 Unknow 14,210 80.64% 9,911 80.36% 4,299 81.30% 109
CA19-9
 Positive 5,371 30.48% 3,734 30.28% 1,637 30,96% 0.63 53
 Negative 12,250 69.52% 8,599 69.72% 3,651 69.04% 96
 Number 0.38
 1 14,333 81.34% 10,043 81.43% 4,290 81.13% 105
 >1 3,288 18.66% 2,290 18.57% 998 18.87% 44
 Radiation 0.29
 Yes 1,789 10.15% 1,285 10.42% 504 9.53% 34
 No 15,832 89.85% 11,048 89.58% 4,784 90.47% 115
Chemotherapy
 Yes 10,784 61.20% 7,493 60.76% 3,291 62.24% 0.36 97
 No 6,837 38.80% 4,840 39.24% 1,997 37.76% 52

Clinical information on patients aged ≥50 years with advanced pancreatic ductal adenocarcinoma.

a

Well: Grades I and II; Bad: Grades III and IV.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

advanced pancreatic ductal adenocarcinoma, nomogram, AJCC staging, risk stratification, cancer-specific survival

Citation

Feng Y, Yang J, Duan W, Cai Y, Liu X and Peng Y (2024) Corrigendum: LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research. Front. Oncol. 14:1370998. doi: 10.3389/fonc.2024.1370998

Received

15 January 2024

Accepted

18 January 2024

Published

07 February 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2024

Updates

Copyright

*Correspondence: Yong Peng,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics